ATE514090T1 - Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungen - Google Patents
Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungenInfo
- Publication number
- ATE514090T1 ATE514090T1 AT10158956T AT10158956T ATE514090T1 AT E514090 T1 ATE514090 T1 AT E514090T1 AT 10158956 T AT10158956 T AT 10158956T AT 10158956 T AT10158956 T AT 10158956T AT E514090 T1 ATE514090 T1 AT E514090T1
- Authority
- AT
- Austria
- Prior art keywords
- marker
- colorectal carcinoma
- cancer diseases
- differentiate
- satb2
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 2
- 102100032883 DNA-binding protein SATB2 Human genes 0.000 title abstract 2
- 101000655236 Homo sapiens DNA-binding protein SATB2 Proteins 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000003550 marker Substances 0.000 title abstract 2
- 201000010989 colorectal carcinoma Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06114954A EP1862803A1 (de) | 2006-06-02 | 2006-06-02 | Verwendung des Proteins SATB2 als Marker für kolorektale Karzinome |
| US81661306P | 2006-06-27 | 2006-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE514090T1 true ATE514090T1 (de) | 2011-07-15 |
Family
ID=36968849
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10158956T ATE514090T1 (de) | 2006-06-02 | 2007-06-04 | Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungen |
| AT07725799T ATE513216T1 (de) | 2006-06-02 | 2007-06-04 | Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07725799T ATE513216T1 (de) | 2006-06-02 | 2007-06-04 | Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8067190B2 (de) |
| EP (3) | EP1862803A1 (de) |
| JP (2) | JP4990970B2 (de) |
| CN (2) | CN103293307B (de) |
| AT (2) | ATE514090T1 (de) |
| AU (1) | AU2007256391B2 (de) |
| CA (1) | CA2653952A1 (de) |
| DK (2) | DK2211180T3 (de) |
| ES (1) | ES2367412T3 (de) |
| PL (1) | PL2211180T3 (de) |
| WO (1) | WO2007140966A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100662821B1 (ko) * | 2006-04-05 | 2006-12-28 | 유니트마 주식회사 | 레시피언트 블록 성형용 몰드 및 이를 이용한 레시피언트블록의 제조방법 |
| EP1862803A1 (de) | 2006-06-02 | 2007-12-05 | Atlas Antibodies AB | Verwendung des Proteins SATB2 als Marker für kolorektale Karzinome |
| EP2107375A1 (de) * | 2008-03-31 | 2009-10-07 | Atlas Antibodies AB | Verwendungen von WARS-Protein bei der Krebsprognose |
| EP2172477A1 (de) | 2008-10-06 | 2010-04-07 | Atlas Antibodies AB | Neue Epitope und Verwendungen davon |
| WO2010091763A1 (en) * | 2009-02-16 | 2010-08-19 | Atlas Antibodies Ab | Rbm3 as a marker for malignant melanoma prognosis |
| WO2015172249A1 (en) | 2014-05-13 | 2015-11-19 | Vastcon | Methionine aminopeptidase overexpression in the peripheral blood and peripheral blood mononuclear cells is a marker for colorectal cancer screening, diagnosis and prognosis |
| CA2975223C (en) * | 2015-01-30 | 2021-08-24 | Glax Llc | Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer |
| US20160258438A1 (en) * | 2015-03-05 | 2016-09-08 | Regal Beloit America, Inc. | Assembly, blower and associated method |
| US20180282815A1 (en) * | 2015-04-29 | 2018-10-04 | Geneoscopy, Llc | Colorectal cancer screening method and device |
| CN110291197B (zh) | 2016-10-27 | 2024-01-12 | 基因复制股份有限公司 | 检测方法 |
| CN106841131A (zh) * | 2016-12-29 | 2017-06-13 | 上海交通大学 | 一种基于角蛋白自荧光作为预测检测肿瘤的生物标志物的检测方法及其应用 |
| WO2019232483A1 (en) | 2018-06-01 | 2019-12-05 | Geneoscopy, Llc | Detection method |
| WO2020031206A1 (en) * | 2018-08-08 | 2020-02-13 | Indian Institute Of Science Education And Research | Combined expression pattern of satb family chromatin organizers as improved biomarker tool for cancer prognosis |
| US12435335B2 (en) | 2022-06-06 | 2025-10-07 | Cornell University | Promoting nutrient absorption through the colon |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9828840D0 (en) | 1998-12-30 | 1999-02-17 | Univ Nottingham Trent | Prostate cancer associated genes and their products |
| DE19932688B4 (de) | 1999-07-13 | 2009-10-08 | Scil Proteins Gmbh | Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen |
| US20030129207A1 (en) * | 2001-08-21 | 2003-07-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| US20090215711A1 (en) * | 2004-04-30 | 2009-08-27 | Sagres Discovery, Inc. | Novel compositions and methods in cancer |
| DE102004037860A1 (de) * | 2004-08-04 | 2006-03-16 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen |
| CN102191320A (zh) * | 2005-05-02 | 2011-09-21 | 东丽株式会社 | 用于诊断食管癌的组合物及方法 |
| GB2435882A (en) | 2006-03-09 | 2007-09-12 | Bioinvent Int Ab | Detection and treatment of mantle cell lymphoma |
| EP1862803A1 (de) | 2006-06-02 | 2007-12-05 | Atlas Antibodies AB | Verwendung des Proteins SATB2 als Marker für kolorektale Karzinome |
-
2006
- 2006-06-02 EP EP06114954A patent/EP1862803A1/de not_active Withdrawn
-
2007
- 2007-06-04 PL PL10158956T patent/PL2211180T3/pl unknown
- 2007-06-04 US US12/302,248 patent/US8067190B2/en active Active
- 2007-06-04 EP EP07725799A patent/EP2024747B1/de not_active Not-in-force
- 2007-06-04 EP EP10158956A patent/EP2211180B1/de active Active
- 2007-06-04 DK DK10158956.2T patent/DK2211180T3/da active
- 2007-06-04 CN CN201310187869.7A patent/CN103293307B/zh active Active
- 2007-06-04 JP JP2009512511A patent/JP4990970B2/ja active Active
- 2007-06-04 WO PCT/EP2007/004931 patent/WO2007140966A1/en not_active Ceased
- 2007-06-04 DK DK07725799.6T patent/DK2024747T3/da active
- 2007-06-04 AU AU2007256391A patent/AU2007256391B2/en not_active Ceased
- 2007-06-04 AT AT10158956T patent/ATE514090T1/de not_active IP Right Cessation
- 2007-06-04 CN CNA2007800204929A patent/CN101460850A/zh active Pending
- 2007-06-04 CA CA002653952A patent/CA2653952A1/en not_active Abandoned
- 2007-06-04 ES ES10158956T patent/ES2367412T3/es active Active
- 2007-06-04 AT AT07725799T patent/ATE513216T1/de not_active IP Right Cessation
-
2011
- 2011-10-21 US US13/278,473 patent/US8241859B2/en not_active Expired - Fee Related
- 2011-10-28 JP JP2011237699A patent/JP5301630B2/ja not_active Expired - Fee Related
-
2012
- 2012-07-06 US US13/542,723 patent/US8465934B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2653952A1 (en) | 2007-12-13 |
| WO2007140966A1 (en) | 2007-12-13 |
| AU2007256391A1 (en) | 2007-12-13 |
| US20120028836A1 (en) | 2012-02-02 |
| AU2007256391B2 (en) | 2011-05-19 |
| EP2024747B1 (de) | 2011-06-15 |
| EP1862803A1 (de) | 2007-12-05 |
| DK2024747T3 (da) | 2011-09-19 |
| CN101460850A (zh) | 2009-06-17 |
| US20120270956A1 (en) | 2012-10-25 |
| US8465934B2 (en) | 2013-06-18 |
| PL2211180T3 (pl) | 2011-11-30 |
| US8067190B2 (en) | 2011-11-29 |
| JP4990970B2 (ja) | 2012-08-01 |
| EP2024747A1 (de) | 2009-02-18 |
| US20090220975A1 (en) | 2009-09-03 |
| JP5301630B2 (ja) | 2013-09-25 |
| DK2211180T3 (da) | 2011-09-26 |
| ES2367412T3 (es) | 2011-11-03 |
| EP2211180B1 (de) | 2011-06-22 |
| ATE513216T1 (de) | 2011-07-15 |
| JP2012073260A (ja) | 2012-04-12 |
| CN103293307B (zh) | 2016-03-23 |
| EP2211180A1 (de) | 2010-07-28 |
| CN103293307A (zh) | 2013-09-11 |
| US8241859B2 (en) | 2012-08-14 |
| JP2009539082A (ja) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE514090T1 (de) | Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungen | |
| ATE450547T1 (de) | Eml4-alk-fusionsgen | |
| ATE527385T1 (de) | Mit tumoren assoziierte genetische variationen | |
| MX2007010349A (es) | Composiciones y metodos para clasificar muestras biologicas. | |
| WO2010045318A3 (en) | Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type | |
| WO2006110581A3 (en) | Cancer-related genes | |
| WO2008039769A3 (en) | Methods and devices for analyzing small rna molecules | |
| ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| GB0607943D0 (en) | Biomarkers for chronic transplant dysfunction | |
| WO2007149476A3 (en) | Assays for non-apoptotic cell death and uses thereof | |
| WO2012154567A3 (en) | Human invasion signature for prognosis of metastatic risk | |
| UA101814C2 (ru) | Фактор, задействованный в латентной инфекции герпесвирусом, и его применение | |
| CY1112553T1 (el) | Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος | |
| WO2011008746A3 (en) | Serum markers associated with early and other stages of breast cancer | |
| ATE491809T1 (de) | Amplifikation von dna-fragmenten | |
| ATE544070T1 (de) | Verfahren zum nachweis von tumorspezifischen fusionsproteinen | |
| WO2007112054A3 (en) | Facilitation of translocation of molecules through the gastrointestinal tract | |
| DE602007008872D1 (de) | Mikrowellengestützte deglycosylierung von proteinen zur molekulargewichtsbestimmung durch massenspektrometrie | |
| EP2386633A4 (de) | Neues tumorantigen eef2 | |
| WO2006034278A3 (en) | Methods and compositions for detecting cancer using components of the u2 spliceosomal particle | |
| WO2007087263A3 (en) | Human zip1, zinc and citrate for prostate cancer screening | |
| WO2008108873A3 (en) | Molecular biosensors for detecting macromolecules and other analytes | |
| WO2009019369A3 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal | |
| ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
| ATE412182T1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |